Harmony Biosciences Holdings, Inc.

NasdaqGM:HRMY 주식 보고서

시가총액: US$2.2b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Harmony Biosciences Holdings 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Jeffrey Dayno

최고 경영자

US$4.5m

총 보상

CEO 급여 비율13.8%
CEO 임기1.7yrs
CEO 소유권n/a
경영진 평균 재임 기간3.6yrs
이사회 평균 재임 기간4.1yrs

최근 관리 업데이트

Recent updates

Many Still Looking Away From Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Sep 25
Many Still Looking Away From Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Harmony Biosciences: Advancing An Expanded Pipeline

Aug 15

Harmony Biosciences Holdings (NASDAQ:HRMY) Has A Rock Solid Balance Sheet

Jul 15
Harmony Biosciences Holdings (NASDAQ:HRMY) Has A Rock Solid Balance Sheet

Investors Holding Back On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Jun 07
Investors Holding Back On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Harmony Biosciences Holdings, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 03
Harmony Biosciences Holdings, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

These 4 Measures Indicate That Harmony Biosciences Holdings (NASDAQ:HRMY) Is Using Debt Safely

Apr 04
These 4 Measures Indicate That Harmony Biosciences Holdings (NASDAQ:HRMY) Is Using Debt Safely

Market Cool On Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Earnings

Feb 09
Market Cool On Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Earnings

Fewer Investors Than Expected Jumping On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Mar 21
Fewer Investors Than Expected Jumping On Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Does Harmony Biosciences Holdings (NASDAQ:HRMY) Deserve A Spot On Your Watchlist?

Dec 01
Does Harmony Biosciences Holdings (NASDAQ:HRMY) Deserve A Spot On Your Watchlist?

Harmony Biosciences: In Harmony

Sep 23

We Ran A Stock Scan For Earnings Growth And Harmony Biosciences Holdings (NASDAQ:HRMY) Passed With Ease

Aug 05
We Ran A Stock Scan For Earnings Growth And Harmony Biosciences Holdings (NASDAQ:HRMY) Passed With Ease

Harmony Biosciences Non-GAAP EPS of $0.57 misses by $0.06, revenue of $107M beats by $6.25M

Aug 02

Harmony Biosciences: Steady Revenue Generator Looking For A Future

May 26

Harmony Biosciences: Strong Growth At A Reasonable Price

Mar 04

Our First Look At Harmony Biosciences

Nov 04

CEO 보상 분석

Jeffrey Dayno 의 보수는 Harmony Biosciences Holdings 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

US$115m

Mar 31 2024n/an/a

US$138m

Dec 31 2023US$4mUS$613k

US$129m

Sep 30 2023n/an/a

US$151m

Jun 30 2023n/an/a

US$200m

Mar 31 2023n/an/a

US$189m

Dec 31 2022US$762kUS$459k

US$181m

Sep 30 2022n/an/a

US$156m

Jun 30 2022n/an/a

US$58m

Mar 31 2022n/an/a

US$49m

Dec 31 2021US$703kUS$446k

US$35m

Sep 30 2021n/an/a

US$12m

Jun 30 2021n/an/a

US$17m

Mar 31 2021n/an/a

-US$7m

Dec 31 2020US$3mUS$431k

-US$64m

Sep 30 2020n/an/a

-US$110m

Jun 30 2020n/an/a

-US$146m

Mar 31 2020n/an/a

-US$165m

Dec 31 2019US$672kUS$414k

-US$187m

보상 대 시장: Jeffrey 의 총 보상 ($USD 4.45M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 5.67M ).

보상과 수익: Jeffrey 의 보상은 작년에 20% 이상 증가한 반면 회사 수익은 20% 이상 감소했습니다.


CEO

Jeffrey Dayno (67 yo)

1.7yrs

테뉴어

US$4,450,294

보상

Dr. Jeffrey M. Dayno, M.D. serves as President, Chief Executive Officer and Director at Harmony Biosciences, LLC since 2023 and served as its Interim President and Chief Executive Officer since January 06,...


리더십 팀

이름위치테뉴어보상소유권
Jeffrey Aronin
Founder & Non-Executive Chairman6.9yrsUS$185.67k0.44%
$ 9.9m
Jeffrey Dayno
President1.7yrsUS$4.45m데이터 없음
Sandip Kapadia
Executive VP3.5yrsUS$5.58m0.012%
$ 273.3k
Kumar Budur
Executive VP and Chief Medical & Scientific Officerless than a yearUS$760.81k0.0018%
$ 39.4k
Jeffrey Dierks
Executive VP & Chief Commercial Officer6.2yrsUS$5.60m0%
$ 0
Andrew Serafin
Executive VP & Chief Strategy Officer5.8yrsUS$647.43k0%
$ 0
David Bradshaw
Head of Technical Operationsno data데이터 없음데이터 없음
Brennan Doyle
VP & Head of Investor Relationsno data데이터 없음데이터 없음
Christian Ulrich
General Counsel & Corporate Secretary3.7yrs데이터 없음데이터 없음
Tricia Glover
Chief Compliance Officer3.3yrs데이터 없음데이터 없음
Audrey Murphy
Vice Presidet of Human Resourcesno data데이터 없음데이터 없음
Cate McCanless
Head of Corporate Affairs & Public Policyno data데이터 없음데이터 없음

3.6yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: HRMY 의 관리팀은 경험 ( 3.3 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Jeffrey Aronin
Founder & Non-Executive Chairman6.9yrsUS$185.67k0.44%
$ 9.9m
Jeffrey Dayno
President1.7yrsUS$4.45m데이터 없음
Andreas Wicki
Independent Director7yrs데이터 없음데이터 없음
R. Graf
Independent Director3.8yrsUS$179.99k0%
$ 0
Gary Sender
Independent Director4.1yrsUS$303.00k0%
$ 0
Antonio Gracias
Independent Director7yrsUS$235.00k0%
$ 0
Peter Anastasiou
Independent Directorless than a yearUS$132.51k데이터 없음
Linda Szyper
Independent Director2.8yrsUS$174.99k0%
$ 0
Juan Sabater
Independent Director7.7yrsUS$179.99k0%
$ 0

4.1yrs

평균 재임 기간

59yo

평균 연령

경험이 풍부한 이사회: HRMY 의 이사회경험(평균 재직 기간 5.3 년)으로 간주됩니다.